Reporting Checklist for Nature Neuroscience

Size: px
Start display at page:

Download "Reporting Checklist for Nature Neuroscience"

Transcription

1 Corresponding Author: Manuscript Number: Manuscript Type: Hillel Adesnik NNA58169T Article Reporting Checklist for Nature Neuroscience # Main ures: 5 # lementary ures: 6 # lementary Tables: 1 # lementary Videos: 0 This checklist is us to ensure good ing standards and to improve the reproducibility of publish results. For more information, please read Reporting Life Sciences Research. Please e that in the event of publication, it is mandatory that authors include all relevant methodological and statistical information in the manuscript. Statistics ing, by figure example example Please specify the following information for each panel ing quantitative data, and where each item is (section, e.g. Results, & graph number). Each figure should ideally contain an sample size (n) for each experimental group/condition, where n is an number and a range, a clear definition of how n is defin (for example x cells from x slices from x animals from x litters, collect over x days), a description of the statistical test us, the results of the tests, any descriptive statistics and clearly defin error bars if applicable. For any experiments using custom statistics, please indicate the test us and stats obtain for each experiment. Each figure should include a statement of how many times the experiment shown was replicat in the lab; the details of sample collection should be sufficiently clear so that the replicability of the experiment is obvious to the reader. For experiments in the text but in the figures, please use the graph number instead of the figure number. Note: Mean and standard deviation are appropriate on small samples, and plotting independent data points is usually more informative. When technical replicates are, error and significance measures reflect the experimental variability and the variability of the biological process; it is misleading to state this clearly. FIGURE NUMBER 1a results, 6 TEST USED WHICH TEST? oneway unpair t test. Results 6 EXACT VALUE 9, 9, 10, 15 n DEFINED? mice from at least 3 litters/group 15 slices from 10 mice Methods 8 Results 6 DESCRIPTIVE STATS (AVERAGE, VARIANCE) REPORTED? error bars are mean / error bars are mean /. Results 6 P VALUE EXACT VALUE p = p = Results 6 DEGREES OF FREEDOM & F/t/z/R/ETC VALUE VALUE F(3, 36) = 2.97 t(28) = Results 6 nature neuroscience ing checklist March

2 FIGURE NUMBER 1c 1e 1f b & a & 4b & 5c & 5e & TEST USED WHICH TEST? rank sum test rank sum test & 3 EXACT VALUE n DEFINED? mice (both PV and SOM) one session each mice (both PV and SOM) one session each 17 cells 11 and ,8 & 6 & 7 mice (both PV and SOM) one session each identifi SOM and PV cells FS/PV and put. SOM cells 11 SOM mice 18 PV mice & 3 & 4 3 & 6 & lock L2/3 RS cells lock L2/3 FS cells lock L2/3 RS cells 7 & & & & 7 SOM mice 4 PV mice 10 SOM mice 10 SOM mice & & & & DESCRIPTIVE STATS (AVERAGE, VARIANCE) REPORTED? gamma power with size: error bars are mean / percent ruction w. ori offs. surr. mean / effect of size on IPSP power: error bars are percent ruction w. phase offs. surr. mean / 3 P VALUE EXACT VALUE 3.09e e and results 1 & 3 & 4 DEGREES OF FREEDOM & F/t/z/R/ETC VALUE VALUE chi2 = z = 3.52 chi2 = e4 3 PPC mean / z = Hz / gamma power ctrl vs SOM : mean / gamma power ctrl vs PV : mean / PPC ctrl. vs.som PPC ctrl. vs.som PPC ctrl. vs.pv stim frequency on band power (SOM) stim frequency on band power (PV) coherence iso vs. cross: mean =/ coherence ctrl. vs. SOM : mean / z = e4 5.03e4 & 6 & 7 z = 1.37 z = 3.60 z = z = 2.59 legen legen legen legen 3.17e a & 4a & 5c & 5e & chi2 = chi2 = nature neuroscience ing checklist March

3 l. 1a l. 1b l. 1c l. 1g l 1i l. 2b l. 2b l. 2b l. 2b l. 2b l. 2e l. 3b l. 3b l. 3b l. 3b l. 3b l. 5a l. 5a correlation coefficient 25 mice (SOM and PV) 8 mice 4 mice 22 mice 32 mice mice mice mice 7 mice 11 mice mice 18 mice 18 mice 18 mice 8 mice mice 11 mice mice high gamma with size: error bars are mean / high gamma with contrast: error bars are mean / high gamma with luminance: error bars are mean / high gamma running vs. quiescent peak frequency with size: error bars are mean / relative gama power ctrl vs. SOM peak/trough gamma power ctrl. vs. SOM absolute gamma power ctrl vs. SOM absolute gamma power (light before vis) ctrl vs. SOM high gamma power ctrl. vs. SOM gamma center frequency with center ruc frequency with SOM relative gama power ctrl vs. PV peak/trough gamma power ctrl. vs. PV absolute gamma power ctrl vs. PV absolute gamma power (light before vis) ctrl vs. PV high gamma power ctrl. vs. PV gamma power (nonrunning) ctrl. vs. SOM gamma power (nonrunning) ctrl. vs. PV 3.04e e e e e e e lgen chi2 = chi2 = chi2 = z = 4.04 chi2 = r = 0.78 z = 1.85 z = 0.07 z = 3.72 nature neuroscience ing checklist March f & & pairs Legen cross spectral power: Control vs. Feback vs. Pseudofeback Legen 8.95e08 & chi2 =

4 4f & 11 l. 6a l. 6a l. 6a Friman test 2way 2way 2way 4f & pairs Legen 7 cells Representative figures 6 and 4 mice 6 and 4 mice 3 and 4 mice 1. Are any representative images shown (including Western blots and immunohistochemistry/staining) in the paper? If so, what figure(s)? 2. For each representative image, is there a clear statement of how many times this experiment was successfully repeat and a discussion of any limitations in repeatability? If so, where is this (section, graph #)? Statistics and general methods 1. Is there a justification of the sample size? If so, how was it justifi? Even if no sample size calculation was perform, authors should why the sample size is adequate to measure their effect size. 2. Are statistical tests justifi as appropriate for every figure? a. If there is a section summarizing the statistical methods in the methods, is the statistical test for each experiment clearly defin? b. Do the data meet the assumptions of the specific statistical test you chose (e.g. normality for a metric test)? Where is this describ (section, graph #)? zero peak of cross correlation: Control vs. Feback vs. Pseudofeback IPSP power control vs. light effect of anesthesia on foldincrease anesthesiafrequency interaction effect of brain area on fold increase Legen 4.3e6 Legend & chi2 = chi2 = yes, supplemental figures 3a and 4a F = F = 7.54 F = 0.6 Virally induc opsin expression in SOM and PV mice was repeat in all mice on here. There is no challenge in repeatability using the describ protocol. Sample size was explicitly chosen and we collect data from as many cells as possible. In each case, a specific number of mice were available, they were record from, and the data was analyz. We us only nonmetric tests to determine significance except for l. 6a where we us a 2way to test for interaction terms. Each figure states the test, number of samples and the p value for each test. There is a statistics section in the methods. tests, rank sum test, Friman test and the do require any assumptions to be met. We did specifically test for normality of the residuals for the in l 6a. nature neuroscience ing checklist March

5 c. Is there any estimate of variance within each group of data? Is the variance similar between groups that are being statistically compar? Where is this describ (section, graph #)? Differences in variance within and between groups was perform by the KW d. Are tests specifi as one or twosid? all tests are twosid and pair, rank sum are twosid e. Are there adjustments for multiple comparisons? no multiple comparisons were perform 3. To promote transparency, Nature Neuroscience has stopp allowing bar graphs to statistics in the papers it publishes. If you have bar graphs in your paper, please make sure to switch them to dotplots (with central and dispersion statistics display) or to boxandwhisker plots to show data distributions. 4. Are criteria for excluding data points? Was this criterion establish prior to data collection? Where is this describ (section, graph #)? 5. Define the method of randomization us to assign subjects (or samples) to the experimental groups and to collect and process data. If no randomization was us, state so. Where does this appear (section, graph #)? 6. Is a statement of the extent to which investigator knew the group allocation during the experiment and in assessing outcome includ? If no blinding was done, state so. 7. For experiments in live vertebrates, is a statement of compliance with ethical guidelines/regulations includ? 8. Is the species of the animals us? 9. Is the strain of the animals (including background strains of KO/ transgenic animals us)? there are no bar graphs in the figures yes yes methods section no randomization was necessary no blinding was done nature neuroscience ing checklist March Is the sex of the animals/subjects us? both male and female mice were us, methods section 5

6 11. Is the age of the animals/subjects?. For animals hous in a vivarium, is the light/dark cycle?. For animals hous in a vivarium, is the housing group (i.e. number of animals per cage)?. For behavioral experiments, is the time of day (e.g. light or dark cycle)? 15. Is the previous history of the animals/subjects (e.g. prior drug administration, surgery, behavioral testing)? a. If multiple behavioral tests were conduct in the same group of animals, is this? 16. If any animals/subjects were exclud from analysis, is this? Reagents a. How were the criteria for exclusion defin? Where is this describ (section, graph #)? b. Specify reasons for any discrepancy between the number of animals at the beginning and end of the study. Where is this describ (section, graph #)? 1. Have antibodies been validat for use in the system under study (assay and species)? a. Is antibody catalog number given? Where does this appear (section, graph #)? no behavioral experiments were perform N/A no exclusions N/A nature neuroscience ing checklist March

7 b. Where were the validation data (citation, supplementary information, Antibodypia)? Where does this appear (section, graph #)? 2. Cell line identity a. Are any cell lines us in this paper list in the database of commonly misidentifi cell lines maintain by ICLAC and NCBI Biosample? b. If yes, include in the Methods section a scientific justification of their useindicate here in which section and graph the justification can be found. c. For each cell line, include in the Methods section a statement that specifies: the source of the cell lines have the cell lines been authenticat? If so, by which method? have the cell lines been test for mycoplasma contamination? N/A nature neuroscience ing checklist March

8 Data availability Provide a Data availability statement in the Methods section under "Data availability", which should include, where applicable: Accession codes for deposit data Other unique identifiers (such as DOIs and hyperlinks for any other datasets) At a minimum, a statement confirming that all relevant data are available from the authors Formal citations of datasets that are assign DOIs A statement regarding data available in the manuscript as source data A statement regarding data available with restrictions See our data availability and data citations policy page for more information. Data deposition in a public repository is mandatory for: a. Protein, DNA and RNA sequences b. Macromolecular structures c. Crystallographic data for small molecules d. Microarray data Deposition is strongly recommend for many other datasets for which structur public repositories exist; more details on our data policy are available here. We encourage the provision of other source data in supplementary information or in unstructur repositories such as share and Dryad. We encourage publication of Data Descriptors (see Scientific Data) to maximize data reuse. Where is the Data Availability statement provid (section, graph #)? Computer code/software all data can be made available upon reasonable request Any custom algorithm/software that is central to the methods must be suppli by the authors in a usable and readable form for readers at the time of publication. However, referees may ask for this information at any time during the review process. 1. Identify all custom software or scripts that were requir to conduct the study and where in the procures each was us. 2. If computer code was us to generate results that are central to the paper's conclusions, include a statement in the Methods section under "Code availability" to indicate whether and how the code can be access. Include version information as necessary and any restrictions on availability. we us MClust spike sorting software (available from the author) and field trip, as well as chronux matlab toolboxes for spectral analysis and coherence estimates (both available online) all code can be made available upon reasonable request nature neuroscience ing checklist March 2016 Human subjects 8

9 1. Which IRB approv the protocol? Where is this stat (section, graph #)? 2. Is demographic information on all subjects provid? 3. Is the number of human subjects, their age and sex clearly defin? 4. Are the inclusion and exclusion criteria (if any) clearly specifi? 5. How well were the groups match? Where is this information describ (section, graph #)? 6. Is a statement includ confirming that inform consent was obtain from all subjects? 7. For publication of patient photos, is a statement includ confirming that consent to publish was obtain? fmri studies For papers ing functional imaging (fmri) results please ensure that these minimal ing guidelines are met and that all this information is clearly provid in the methods: 1. Were any subjects scann but then reject for the analysis after the data was collect? a. If yes, is the number reject and reasons for rejection describ? 2. Is the number of blocks, trials or experimental units per session and/ or subjects specifi? 3. Is the length of each trial and interval between trials specifi? N/A nature neuroscience ing checklist March Is a block, eventrelat, or mix design being us? If applicable, please specify the block length or how the eventrelat or mix design was optimiz. 9

10 5. Is the task design clearly describ? 6. How was behavioral performance measur? 7. Is an or factorial design being us? 8. For data acquisition, is a whole brain scan us? If, state area of acquisition. a. How was this region determin? 9. Is the field strength (in Tesla) of the MRI system stat? a. Is the pulse sequence type (gradient/spin echo, EPI/spiral) stat? b. Are the fieldofview, matrix size, slice thickness, and TE/TR/ flip angle clearly stat? 10. Are the software and specific meters (model/functions, smoothing kernel size if applicable, etc.) us for data processing and preprocessing clearly stat? 11. Is the coordinate space for the anatomical/functional imaging data clearly defin as subject/native space or standardiz stereotaxic space, e.g., original Talairach, MNI305, ICBM152, etc? Where (section, graph #)?. If there was data normalization/standardization to a specific space template, are the type of transformation (linear vs. nonlinear) us and image types being transform clearly describ? Where (section, graph #)?. How were anatomical locations determin, e.g., via an automat labeling algorithm (AAL), standardiz coordinate database (Talairach daemon), probabilistic atlases, etc.?. Were any additional regressors (behavioral covariates, motion etc) us? 15. Is the contrast construction clearly defin? 16. Is a mix/random effects or fix inference us? nature neuroscience ing checklist March 2016 a. If fix effects inference us, is this justifi? 17. Were repeat measures us (multiple measurements per subject)? 10

11 a. If so, are the method to account for within subject correlation and the assumptions made about variance clearly stat? 18. If the threshold us for inference and visualization in figures varies, is this clearly stat? 19. Are statistical inferences correct for multiple comparisons? a. If, is this label as uncorrect? 20. Are the results bas on an ROI (region of interest) analysis? a. If so, is the rationale clearly describ? b. How were the ROI s defin (functional vs anatomical localization)? 21. Is there correction for multiple comparisons within each voxel? 22. For clusterwise significance, is the clusterdefining threshold and the correct significance level defin? Additional comments Additional Comments nature neuroscience ing checklist March

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: Michael Cole NNA51 Article Reporting Checklist for Nature Neuroscience # Main Figures: 5 # lementary Figures: 4 # lementary Tables: 0 # lementary

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: Leonard Petrucelli NNA52530C Article Reporting Checklist for Nature Neuroscience # Main s: 8 # Supplementary s: 10 # Supplementary Tables: 3 #

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: McColl NNRS50586AZ Resource Reporting Checklist for Nature Neuroscience # Main Figures: 8 # lementary Figures: 7 # lementary Tables: 13 # lementary

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: Feltri NNA54268B Article Reporting Checklist for Nature Neuroscience # Main Figures: 7 # Supplementary Figures: 5 # Supplementary Tables: 1 # Supplementary

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: Yang Dan NNA56598 Article Reporting Checklist for Nature Neuroscience # Main Figures: 8 # Supplementary Figures: 12 # Supplementary Tables: 0 #

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: Robert Froemke NNA7412T Article Reporting Checklist for Nature Neuroscience # Main s: 7 # Supplementary s: 14 # Supplementary Tables: 0 # Supplementary

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: Liu NNA52890T Article Reporting Checklist for Nature Neuroscience # Main Figures: 4 # Supplementary Figures: 3 # Supplementary Tables: 1 # Supplementary

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: xiangdong fu, yuanchao xue NNA52804A Article Reporting Checklist Nature Neuroscience # Main Figures: 5 # Supplementary Figures: 7 # Supplementary

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: David Dupret NNBC5329A Brief Communication Reporting Checklist for Nature Neuroscience # s: 3 # s: 11 # Tables: 0 # Videos: 0 This checklist is

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: RuRong Ji NNA59063A Article Reporting Checklist for Nature Neuroscience # Main ures: 8 # Supplementary ures: 15 # Supplementary Tables: 0 # Supplementary

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: Chay T. Kuo NNA47008 Article Reporting Checklist for Nature Neuroscience # Main Figures: 7 # Supplementary Figures: 11 # Supplementary Tables:

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corponding Author: Manuscript Number: Manuscript Type: Gregory C. DeAngelis NNA49009A Article Reporting Checklist for Nature Neuroscience # Main Figu: 7 # lementary Figu: # lementary Tables: 0 # lementary

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: Lennart Mucke NNRS49607AZ Resource Reporting Checklist for Nature Neuroscience # Main s: # lementary s: 4 # lementary Tables: 9 # lementary Videos:

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: Rachel Wilson NNA48246B Article Reporting Checklist for Nature Neuroscience # Main Figures: 8 # Supplementary Figures: 7 # Supplementary Tables:

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Marcelo Coba Manuscript Number: NNRS3314D Manuscript Type: Resource Reporting Checklist for Nature Neuroscience # Main Figures: 7 # lementary Figures: 4 # lementary Tables: 11 # lementary

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: Ofer Yizhar, PhD NNA54616C Article Reporting Checklist for Nature Neuroscience # Main s: 5 # lementary s: 10 # lementary Tables: 0 # lementary

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: Atsushi Miyawaki NNT51493A Technical Report Reporting Checklist Nature Neuroscience # Main Figures: 7 # Supplementary Figures: 12 # Supplementary

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: Benjamin R. Rost NNT51693 Technical Report Reporting Checklt for Nature Neuroscience # Main Figures: 6 # Supplementary Figures: 9 # Supplementary

More information

Life Sciences Reporting Summary

Life Sciences Reporting Summary Life Sciences Reporting Summary Adams Waldorf, Rajagopal, Gale Initial submission Revised version Final submission Nature Research wishes to improve the reproducibility of the work that we publish. This

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Correspondg Author: Manuscript Number: Manuscript Type: Spencer Smith NNA48000A Article Reportg Checklist for Nature Neuroscience # Ma Figures: 6 # Supplementary Figures: 8 # Supplementary Tables: 1 #

More information

Life Sciences Reporting Summary

Life Sciences Reporting Summary Life Sciences Reporting Summary Corresponding author(s): Rich, Jeremy N. Initial submission Revised version Final submission Nature Research wishes to improve the reproducibility of the work that we publish.

More information

Our web collection on statistics for biologists may be useful.

Our web collection on statistics for biologists may be useful. Reporting Summary Corresponding author(s): FELIPE CAVA Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency in

More information

Jeffrey W. Elias, PhD UCD SOM Office of Research Grants Facilitation.

Jeffrey W. Elias, PhD UCD SOM Office of Research Grants Facilitation. NIH IS CHANGING/ENHANCING THE REVIEW CRITERIA AND FOCUSING ON MISSING OPPORTUNITIES TO EXAMINE SEX DIFFERENCES JOURNALS ARE CHANGING/ENHANCING THE REVIEW CRITERIA Jeffrey W. Elias, PhD UCD SOM Office of

More information

Efforts to Improve Data Transparency at the JBC

Efforts to Improve Data Transparency at the JBC Efforts to Improve Data Transparency at the JBC Roger J. Colbran Associate Editor Credit: Amanda Fosang, Associate Editor 2 Why Improve Transparency? Irreproducibility of pre-clinical studies Negative

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION DOI: 10.1038/ncb3575 In the format provided by the authors and unedited. Supplementary Figure 1 Validation of key reagents and assays a, top, IHC with antibody recognizing specifically

More information

PROMOTING TRANSPARENT RESEARCH METHODS, PROTOCOLS AND DATA TO REDUCE IRREPRODUCIBILITY

PROMOTING TRANSPARENT RESEARCH METHODS, PROTOCOLS AND DATA TO REDUCE IRREPRODUCIBILITY PROMOTING TRANSPARENT RESEARCH METHODS, PROTOCOLS AND DATA TO REDUCE IRREPRODUCIBILITY December 2015 STM Innovations Seminar Andrew L Hufton, PhD Managing Editor, Scientific Data Nature Publishing Group

More information

Reporting Summary. Statistical parameters. Software and code. nature research reporting summary April Corresponding author(s):

Reporting Summary. Statistical parameters. Software and code. nature research reporting summary April Corresponding author(s): Reporting Summary Corresponding author(s): Alexander Flügel 2018-07-09758C Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency

More information

Our web collection on statistics for biologists may be useful.

Our web collection on statistics for biologists may be useful. Reporting Summary Corresponding author(s): Qi-jing Li, Lilin Ye and Bo Zhu Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Coesponding Autho: Manuscipt Numbe: Manuscipt Type: Yuki Oka NNA5991A Aticle Repoting Checklist fo Natue Neuoscience # Main Figues: 7 # Supplementay Figues: # Supplementay Tables: 0 # Supplementay Videos:

More information

Life Sciences Reporting Summary

Life Sciences Reporting Summary Life Sciences Reporting Summary Corresponding author(s): Stein Aerts Initial submission Revised version Final submission Nature Research wishes to improve the reproducibility of the work that we publish.

More information

Important Information for MCP Authors

Important Information for MCP Authors Guidelines to Authors for Publication of Manuscripts Describing Development and Application of Targeted Mass Spectrometry Measurements of Peptides and Proteins and Submission Checklist The following Guidelines

More information

Cerebrospinal fluid tau, neurogranin and neurofilament light in Alzheimerís disease

Cerebrospinal fluid tau, neurogranin and neurofilament light in Alzheimerís disease Cerebrospinal fluid tau, neurogranin and neurofilament light in Alzheimerís disease Niklas Mattsson, Philip Insel, Sebastian Palmqvist, Erik Portelius, Henrik Zetterberg, Michael Weiner, Kaj Blennow, Oskar

More information

Using Excel s Analysis ToolPak Add-In

Using Excel s Analysis ToolPak Add-In Using Excel s Analysis ToolPak Add-In Bijay Lal Pradhan, PhD Introduction I have a strong opinions that we can perform different quantitative analysis, including statistical analysis, in Excel. It is powerful,

More information

Lab 1: A review of linear models

Lab 1: A review of linear models Lab 1: A review of linear models The purpose of this lab is to help you review basic statistical methods in linear models and understanding the implementation of these methods in R. In general, we need

More information

Differential expression analysis for sequencing count data. Simon Anders

Differential expression analysis for sequencing count data. Simon Anders Differential expression analysis for sequencing count data Simon Anders Two applications of RNA-Seq Discovery find new transcripts find transcript boundaries find splice junctions Comparison Given samples

More information

Revision Checklist for Science Signaling Research Manuscripts: Data Requirements and Style Guidelines

Revision Checklist for Science Signaling Research Manuscripts: Data Requirements and Style Guidelines Revision Checklist for Science Signaling Research Manuscripts: Data Requirements and Style Guidelines Further information can be found at: http://stke.sciencemag.org/sites/default/files/researcharticlerevmsinstructions_0.pdf.

More information

AP Statistics Scope & Sequence

AP Statistics Scope & Sequence AP Statistics Scope & Sequence Grading Period Unit Title Learning Targets Throughout the School Year First Grading Period *Apply mathematics to problems in everyday life *Use a problem-solving model that

More information

Edinburgh Research Explorer

Edinburgh Research Explorer Edinburgh Research Explorer Protocol for a retrospective, controlled cohort study of the impact of a change in Nature journals' editorial policy for life sciences research on the completeness of reporting

More information

STAT 2300: Unit 1 Learning Objectives Spring 2019

STAT 2300: Unit 1 Learning Objectives Spring 2019 STAT 2300: Unit 1 Learning Objectives Spring 2019 Unit tests are written to evaluate student comprehension, acquisition, and synthesis of these skills. The problems listed as Assigned MyStatLab Problems

More information

Integrative Genomics 1a. Introduction

Integrative Genomics 1a. Introduction 2016 Course Outline Integrative Genomics 1a. Introduction ggibson.gt@gmail.com http://www.cig.gatech.edu 1a. Experimental Design and Hypothesis Testing (GG) 1b. Normalization (GG) 2a. RNASeq (MI) 2b. Clustering

More information

Aims and challenges of clinical trial data sharing

Aims and challenges of clinical trial data sharing Aims and challenges of clinical trial data sharing Facilitating data access to non-industry funded research UCL and Yale meeting: 9 October 2015 London Dr Trish Groves Head of research,

More information

Practical What & Where of Rigor and Reproducibility in the NIH Application. SIU School of Medicine Office of Grants & Contracts with Sophia Ran, PhD

Practical What & Where of Rigor and Reproducibility in the NIH Application. SIU School of Medicine Office of Grants & Contracts with Sophia Ran, PhD Practical What & Where of Rigor and Reproducibility in the NIH Application SIU School of Medicine Office of Grants & Contracts with Sophia Ran, PhD Recent Training Sessions NIH Regional Seminar Rigor and

More information

Microarray Gene Expression Analysis at CNIO

Microarray Gene Expression Analysis at CNIO Microarray Gene Expression Analysis at CNIO Orlando Domínguez Genomics Unit Biotechnology Program, CNIO 8 May 2013 Workflow, from samples to Gene Expression data Experimental design user/gu/ubio Samples

More information

BIOEQUIVALENCE TRIAL INFORMATION

BIOEQUIVALENCE TRIAL INFORMATION PRESENTATION OF BIOEQUIVALENCE TRIAL INFORMATION BIOEQUIVALENCE TRIAL INFORMATION GENERAL INSTRUCTIONS: Please review all the instructions thoroughly and carefully prior to completing the Bioequivalence

More information

ENCODE RBP Antibody Characterization Guidelines

ENCODE RBP Antibody Characterization Guidelines ENCODE RBP Antibody Characterization Guidelines Approved on November 18, 2016 Background An integral part of the ENCODE Project is to characterize the antibodies used in the experiments. This document

More information

BIOEQUIVALENCE TRIAL INFORMATION FORM (Medicines and Allied Substances Act [No. 3] of 2013 Part V Section 39)

BIOEQUIVALENCE TRIAL INFORMATION FORM (Medicines and Allied Substances Act [No. 3] of 2013 Part V Section 39) ZAMRA BTIF BIOEQUIVALENCE TRIAL INFORMATION FORM (Medicines and Allied Substances Act [No. 3] of 2013 Part V Section 39) The Guidelines on Bioequivalence Studies to be consulted in completing this form.

More information

QPCR ASSAYS FOR MIRNA EXPRESSION PROFILING

QPCR ASSAYS FOR MIRNA EXPRESSION PROFILING TECH NOTE 4320 Forest Park Ave Suite 303 Saint Louis, MO 63108 +1 (314) 833-9764 mirna qpcr ASSAYS - powered by NAWGEN Our mirna qpcr Assays were developed by mirna experts at Nawgen to improve upon previously

More information

Animal Research Ethics Committee. Guidelines for Submitting Protocols for ethical approval of research or teaching involving live animals

Animal Research Ethics Committee. Guidelines for Submitting Protocols for ethical approval of research or teaching involving live animals Animal Research Ethics Committee Guidelines for Submitting Protocols for ethical approval of research or teaching involving live animals AREC Document No: 3 Revised Guidelines for Submitting Protocols

More information

iphemap: An atlas of Phenotype to genotype relationships of human ipsc models of neurological diseases

iphemap: An atlas of Phenotype to genotype relationships of human ipsc models of neurological diseases iphemap: An atlas of Phenotype to genotype relationships of human ipsc models of neurological diseases Ethan W. Hollingsworth, Jacob E. Vaughn, Josh C. Orack, Chelsea Skinner, Jamil Khouri, Sofia B. Lizarraga,

More information

Methods in Clinical Cancer Research Workshop Format for Protocol Concept Synopsis Sheet (blank) SYNOPSIS

Methods in Clinical Cancer Research Workshop Format for Protocol Concept Synopsis Sheet (blank) SYNOPSIS B Methods in Clinical Cancer Research Workshop Format for Protocol Concept Synopsis Sheet (blank) elow is the format to follow for the concept sheet for protocols. It is based on the International Committee

More information

Crowe Critical Appraisal Tool (CCAT) User Guide

Crowe Critical Appraisal Tool (CCAT) User Guide Crowe Critical Appraisal Tool (CCAT) User Guide Version 1.4 (19 November 2013) Use with the CCAT Form version 1.4 only Michael Crowe, PhD michael.crowe@my.jcu.edu.au This work is licensed under the Creative

More information

Medicines Control Authority Of Zimbabwe

Medicines Control Authority Of Zimbabwe Medicines Control Authority Of Zimbabwe BIOEQUIVALENCE APPLICATION FORM Form: EVF03 This application form is designed to facilitate information exchange between the Applicant and the MCAZ for bioequivalence

More information

Life Sciences Reporting Summary

Life Sciences Reporting Summary Life Sciences Reporting Summary Corresponding author(s): Christer Betsholtz Initial submission Revised version Final submission Nature Research wishes to improve the reproducibility of the work that we

More information

The first thing you will see is the opening page. SeqMonk scans your copy and make sure everything is in order, indicated by the green check marks.

The first thing you will see is the opening page. SeqMonk scans your copy and make sure everything is in order, indicated by the green check marks. Open Seqmonk Launch SeqMonk The first thing you will see is the opening page. SeqMonk scans your copy and make sure everything is in order, indicated by the green check marks. SeqMonk Analysis Page 1 Create

More information

Exploration and Analysis of DNA Microarray Data

Exploration and Analysis of DNA Microarray Data Exploration and Analysis of DNA Microarray Data Dhammika Amaratunga Senior Research Fellow in Nonclinical Biostatistics Johnson & Johnson Pharmaceutical Research & Development Javier Cabrera Associate

More information

Discriminant models for high-throughput proteomics mass spectrometer data

Discriminant models for high-throughput proteomics mass spectrometer data Proteomics 2003, 3, 1699 1703 DOI 10.1002/pmic.200300518 1699 Short Communication Parul V. Purohit David M. Rocke Center for Image Processing and Integrated Computing, University of California, Davis,

More information

Archives of Scientific Psychology Reporting Questionnaire for Manuscripts Describing Primary Data Collections

Archives of Scientific Psychology Reporting Questionnaire for Manuscripts Describing Primary Data Collections (Based on APA Journal Article Reporting Standards JARS Questionnaire) 1 Archives of Scientific Psychology Reporting Questionnaire for Manuscripts Describing Primary Data Collections JARS: ALL: These questions

More information

RIGOR AND REPRODUCIBILITY: BACK TO BASICS

RIGOR AND REPRODUCIBILITY: BACK TO BASICS RIGOR AND REPRODUCIBILITY: BACK TO BASICS OCT 27, 2016 NIH REGIONAL SEMINAR - CHICAGO OVERVIEW Why the concern about reproducibility? The NIH response Updates to grant applications Training and Resources

More information

Alternative TSSs are co-regulated in single cells in the mouse brain

Alternative TSSs are co-regulated in single cells in the mouse brain Alternative TSSs are co-regulated in single cells in the mouse brain Kasper Karlsson, Peter Lönnerberg, Sten Linnarsson Corresponding author: Sten Linnarsson, Karolinska Institutet Review timeline: Submission

More information

Design of Experiments (DOE) Instructor: Thomas Oesterle

Design of Experiments (DOE) Instructor: Thomas Oesterle 1 Design of Experiments (DOE) Instructor: Thomas Oesterle 2 Instructor Thomas Oesterle thomas.oest@gmail.com 3 Agenda Introduction Planning the Experiment Selecting a Design Matrix Analyzing the Data Modeling

More information

Electronic Supplementary Information

Electronic Supplementary Information Electronic Supplementary Material (ESI) for Integrative Biology. This journal is The Royal Society of Chemistry 2015 Electronic Supplementary Information Table S1. Definition of quantitative cellular features

More information

Laboratory Developed Tests. William Castellani, MD Inter-regional Commissioner Clinical Pathologist, Penn State Hershey Medical Center

Laboratory Developed Tests. William Castellani, MD Inter-regional Commissioner Clinical Pathologist, Penn State Hershey Medical Center Laboratory Developed Tests William Castellani, MD Inter-regional Commissioner Clinical Pathologist, Penn State Hershey Medical Center Objectives Compare and contrast new test validation requirements for

More information

FFGWAS. Fast Functional Genome Wide Association AnalysiS of Surface-based Imaging Genetic Data

FFGWAS. Fast Functional Genome Wide Association AnalysiS of Surface-based Imaging Genetic Data FFGWAS Fast Functional Genome Wide Association AnalysiS of Surface-based Imaging Genetic Data Chao Huang Department of Biostatistics Biomedical Research Imaging Center The University of North Carolina

More information

Weka Evaluation: Assessing the performance

Weka Evaluation: Assessing the performance Weka Evaluation: Assessing the performance Lab3 (in- class): 21 NOV 2016, 13:00-15:00, CHOMSKY ACKNOWLEDGEMENTS: INFORMATION, EXAMPLES AND TASKS IN THIS LAB COME FROM SEVERAL WEB SOURCES. Learning objectives

More information

Tutorial Segmentation and Classification

Tutorial Segmentation and Classification MARKETING ENGINEERING FOR EXCEL TUTORIAL VERSION v171025 Tutorial Segmentation and Classification Marketing Engineering for Excel is a Microsoft Excel add-in. The software runs from within Microsoft Excel

More information

Precision in Quantitative Imaging: Trial Development and Quality Assurance

Precision in Quantitative Imaging: Trial Development and Quality Assurance Precision in Quantitative Imaging: Trial Development and Quality Assurance Susanna I Lee MD, PhD Thanks to: Mitchell Schnall, Mark Rosen. Dan Sullivan, Patrick Bossuyt Imaging Chain: Patient Data Raw data

More information

Are You Aware of New Publication Guidelines?

Are You Aware of New Publication Guidelines? Are You Aware of New Publication Guidelines? The application of rigor ensures robust and unbiased experimental design, methodology, analysis, interpretation, and reporting of results. National Institutes

More information

Design of Experiments Example 009 Tabandeh et al (2008) Chemical Engineering Science (63)

Design of Experiments Example 009 Tabandeh et al (2008) Chemical Engineering Science (63) ROK Bioconsulting ronan@rokbioconsulting.com Design of Experiments Example 009 Tabandeh et al (2008) Chemical Engineering Science (63) 2477-2483 Response Surface methodology for optimizing the induction

More information

High-density SNP Genotyping Analysis of Broiler Breeding Lines

High-density SNP Genotyping Analysis of Broiler Breeding Lines Animal Industry Report AS 653 ASL R2219 2007 High-density SNP Genotyping Analysis of Broiler Breeding Lines Abebe T. Hassen Jack C.M. Dekkers Susan J. Lamont Rohan L. Fernando Santiago Avendano Aviagen

More information

PROPENSITY SCORE MATCHING A PRACTICAL TUTORIAL

PROPENSITY SCORE MATCHING A PRACTICAL TUTORIAL PROPENSITY SCORE MATCHING A PRACTICAL TUTORIAL Cody Chiuzan, PhD Biostatistics, Epidemiology and Research Design (BERD) Lecture March 19, 2018 1 Outline Experimental vs Non-Experimental Study WHEN and

More information

FACTORS CONTRIBUTING TO VARIABILITY IN DNA MICROARRAY RESULTS: THE ABRF MICROARRAY RESEARCH GROUP 2002 STUDY

FACTORS CONTRIBUTING TO VARIABILITY IN DNA MICROARRAY RESULTS: THE ABRF MICROARRAY RESEARCH GROUP 2002 STUDY FACTORS CONTRIBUTING TO VARIABILITY IN DNA MICROARRAY RESULTS: THE ABRF MICROARRAY RESEARCH GROUP 2002 STUDY K. L. Knudtson 1, C. Griffin 2, A. I. Brooks 3, D. A. Iacobas 4, K. Johnson 5, G. Khitrov 6,

More information

Executive Summary. clinical supply services

Executive Summary. clinical supply services clinical supply services case study Development and NDA-level validation of quantitative polymerase chain reaction (qpcr) procedure for detection and quantification of residual E.coli genomic DNA Executive

More information

Expectations for Biodistribution (BD) Assessments for Gene Therapy (GT) Products

Expectations for Biodistribution (BD) Assessments for Gene Therapy (GT) Products Expectations for Biodistribution (BD) Assessments for Gene Therapy (GT) Products Approved by the IPRP Management Committee on 3 June 2018 12 April 2018 Table of Contents 1. Position Statement... 3 2. Executive

More information

VALIDATION OF ANALYTICAL PROCEDURES: METHODOLOGY *)

VALIDATION OF ANALYTICAL PROCEDURES: METHODOLOGY *) VALIDATION OF ANALYTICAL PROCEDURES: METHODOLOGY *) Guideline Title Validation of Analytical Procedures: Methodology Legislative basis Directive 75/318/EEC as amended Date of first adoption December 1996

More information

Common Issues in Qualification and Validation of Analytical Procedures

Common Issues in Qualification and Validation of Analytical Procedures Common Issues in Qualification and Validation of Analytical Procedures Alexey Khrenov, PhD OTAT/CBER/FDA CMC Strategy Forum January 29, 2018 - Washington, DC Disclaimer These comments are an informal communication

More information

Estoril Education Day

Estoril Education Day Estoril Education Day -Experimental design in Proteomics October 23rd, 2010 Peter James Note Taking All the Powerpoint slides from the Talks are available for download from: http://www.immun.lth.se/education/

More information

New NIH 2-page Rigor and Transparency Document

New NIH 2-page Rigor and Transparency Document New NIH 2-page Rigor and Transparency Document Grants affected in 2016 include: NOT-OD-16-081 NOT-OD-16-058 NOT-OD-16-034 NOT-OD-16-011 NOT-OD-16-031 NOT-OD-16-012 NOT-OD-16-005 NOT-OD-16-004 NOT-OD-15-103

More information

Guidelines for Developing Robust and Reliable PCR Assays

Guidelines for Developing Robust and Reliable PCR Assays Guidelines for Developing Robust and Reliable PCR Assays Leta Steffen, PhD Applications Scientist Promega Corporation Outline 1) PCR reaction components What is in the reaction? How does it affect assay

More information

Cancer Informatics. Comprehensive Evaluation of Composite Gene Features in Cancer Outcome Prediction

Cancer Informatics. Comprehensive Evaluation of Composite Gene Features in Cancer Outcome Prediction Open Access: Full open access to this and thousands of other papers at http://www.la-press.com. Cancer Informatics Supplementary Issue: Computational Advances in Cancer Informatics (B) Comprehensive Evaluation

More information

Real-time RT PCR. for identification of differentially expressed genes. (with Schizophrenia application) Rolf Sundberg, Stockholm Univ.

Real-time RT PCR. for identification of differentially expressed genes. (with Schizophrenia application) Rolf Sundberg, Stockholm Univ. Real-time RT PCR for identification of differentially expressed genes. (with Schizophrenia application) Rolf Sundberg, Stockholm Univ. Göteborg, May 2006 Real-time PCR for mrna quantitation Review paper

More information

FREQUENTLY ASKED QUESTIONS

FREQUENTLY ASKED QUESTIONS CLINICAL TRIALS FREQUENTLY ASKED QUESTIONS PARTICIPATING IN A CLINICAL TRIAL What is a clinical trial? Clinical trials are research studies that involve people. Through clinical trials, researchers find

More information

ANALYSING QUANTITATIVE DATA

ANALYSING QUANTITATIVE DATA 9 ANALYSING QUANTITATIVE DATA Although, of course, there are other software packages that can be used for quantitative data analysis, including Microsoft Excel, SPSS is perhaps the one most commonly subscribed

More information

ChIP-seq and RNA-seq. Farhat Habib

ChIP-seq and RNA-seq. Farhat Habib ChIP-seq and RNA-seq Farhat Habib fhabib@iiserpune.ac.in Biological Goals Learn how genomes encode the diverse patterns of gene expression that define each cell type and state. Protein-DNA interactions

More information

BIOSTATISTICS AND MEDICAL INFORMATICS (B M I)

BIOSTATISTICS AND MEDICAL INFORMATICS (B M I) Biostatistics and Medical Informatics (B M I) 1 BIOSTATISTICS AND MEDICAL INFORMATICS (B M I) B M I/POP HLTH 451 INTRODUCTION TO SAS PROGRAMMING FOR 2 credits. Use of the SAS programming language for the

More information

Field trial with veterinary vaccine

Field trial with veterinary vaccine ١ Field trial with veterinary vaccine Saeedeh Forghani,, M.D. Clinical Trial and Ethics Department Human Health Management Deputy of Quality Assurance 89/4/2 ٢ ٣ Introduction: The efficacy and safety shall

More information

JGK TRAINING PROGRAMME MODULE 2: METHOD VALIDATION AND MEASUREMENT OF UNCERTAINTY IN VETERINARY LABORATORIES PRACTICAL COURSE

JGK TRAINING PROGRAMME MODULE 2: METHOD VALIDATION AND MEASUREMENT OF UNCERTAINTY IN VETERINARY LABORATORIES PRACTICAL COURSE Registered as JKG Lab AfriQA (Pty) Ltd Reg. No. 2012/154570/07 P.O Box 1581 Potchefstroom 2520 3 Sylvia Street `` Potchefstroom 2531 Tel: +27 18 294 4528 Fax: +27 86 650 1716 Cell: +27 82 562 1858 Email

More information

RayBio Human Caspase-3 ELISA Kit

RayBio Human Caspase-3 ELISA Kit RayBio Human Caspase-3 ELISA Kit Catalog #: ELH-CASP3 User Manual Last revised July 21, 2017 Caution: Extraordinarily useful information enclosed ISO 13485 Certified 3607 Parkway Lane, Suite 100 Norcross,

More information

Codex Committee on Methods of Analysis and Sampling (31 st Session) Budapest, Hungary (8-12 March 2010)

Codex Committee on Methods of Analysis and Sampling (31 st Session) Budapest, Hungary (8-12 March 2010) CRD 13 Codex Committee on Methods of Analysis and Sampling (31 st Session) Budapest, Hungary (8-12 March 2010) European Union comments on the Proposed Draft Guidelines on Criteria for Methods for Detection,

More information

Calculation of Spot Reliability Evaluation Scores (SRED) for DNA Microarray Data

Calculation of Spot Reliability Evaluation Scores (SRED) for DNA Microarray Data Protocol Calculation of Spot Reliability Evaluation Scores (SRED) for DNA Microarray Data Kazuro Shimokawa, Rimantas Kodzius, Yonehiro Matsumura, and Yoshihide Hayashizaki This protocol was adapted from

More information

Bioinformatics for Biologists

Bioinformatics for Biologists Bioinformatics for Biologists Microarray Data Analysis. Lecture 1. Fran Lewitter, Ph.D. Director Bioinformatics and Research Computing Whitehead Institute Outline Introduction Working with microarray data

More information

Validating methods and organizing and analyzing results of interlaboratory comparative tests (CT)

Validating methods and organizing and analyzing results of interlaboratory comparative tests (CT) INTERNATIONAL SEED TESTING ASSOCIATION (ISTA) Secretariat, Zürichstrasse 50, 8303 Bassersdorf, CH-Switzerland Phone: +41-44-838 60 00, Fax: +41-44-838 60 01, Email: ista.office@ista.ch, http://www.seedtest.org

More information